SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: Biotechwantabe who wrote (2817)12/12/2019 11:41:12 AM
From: Biotechwantabe  Respond to of 3557
 
Not market /peak sales projection



To: Biotechwantabe who wrote (2817)12/12/2019 11:59:51 AM
From: Miljenko Zuanic  Respond to of 3557
 
Thanks.

Most intriguing is asthma, +2M WW subjects eligible...at $25K/Y average that is $50B potential. IF real world Dupi clinical asthma results are better than in clinical trials (option not that distant from reality), +10% market penetration is REALITY!

Allergic asthma is huge growing problem, IMO.